NO20031743L - Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav - Google Patents

Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav

Info

Publication number
NO20031743L
NO20031743L NO20031743A NO20031743A NO20031743L NO 20031743 L NO20031743 L NO 20031743L NO 20031743 A NO20031743 A NO 20031743A NO 20031743 A NO20031743 A NO 20031743A NO 20031743 L NO20031743 L NO 20031743L
Authority
NO
Norway
Prior art keywords
venlafaxine
polyforms
novel
preparation
crystalline
Prior art date
Application number
NO20031743A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031743D0 (no
Inventor
Ben-Zion Dolitzky
Judith Aronhime
Shlomit Wizel
Gennady Nisnevish
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27500045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031743(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20031743D0 publication Critical patent/NO20031743D0/no
Publication of NO20031743L publication Critical patent/NO20031743L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20031743A 2000-10-19 2003-04-15 Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav NO20031743L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24157700P 2000-10-19 2000-10-19
US25886100P 2000-12-29 2000-12-29
US27872101P 2001-03-26 2001-03-26
US29246901P 2001-05-21 2001-05-21
PCT/US2001/051017 WO2002045658A2 (en) 2000-10-19 2001-10-19 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof

Publications (2)

Publication Number Publication Date
NO20031743D0 NO20031743D0 (no) 2003-04-15
NO20031743L true NO20031743L (no) 2003-06-18

Family

ID=27500045

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031743A NO20031743L (no) 2000-10-19 2003-04-15 Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav

Country Status (20)

Country Link
US (1) US20020143211A1 (hu)
EP (1) EP1334082A4 (hu)
JP (2) JP2004530638A (hu)
KR (1) KR20030059206A (hu)
CN (1) CN1620420A (hu)
AU (1) AU2002241764A1 (hu)
CA (1) CA2426158A1 (hu)
CZ (1) CZ20031298A3 (hu)
DE (1) DE01988460T1 (hu)
ES (1) ES2206082T1 (hu)
HR (1) HRP20030392A2 (hu)
HU (1) HUP0303496A3 (hu)
IL (2) IL155400A0 (hu)
IS (1) IS6789A (hu)
MX (1) MXPA03003459A (hu)
NO (1) NO20031743L (hu)
PL (1) PL365895A1 (hu)
SK (1) SK5762003A3 (hu)
WO (1) WO2002045658A2 (hu)
YU (1) YU30203A (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
CA2426393C (en) 2000-10-31 2012-05-29 Ciba Specialty Chemicals Holding Inc. Crystalline forms of venlafaxine hydrochloride
HUP0104872A3 (en) * 2001-11-13 2004-04-28 Egis Gyogyszergyar Nyilvanosan New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
CA2467593A1 (en) * 2001-12-05 2003-06-19 Wyeth Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
WO2003050074A1 (en) * 2001-12-13 2003-06-19 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
AU2003226748A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Compositions of venlafaxine base
AR039164A1 (es) 2002-03-28 2005-02-09 Synthon Bv Sales de venlafaxina de baja solubilidad en agua
AR039163A1 (es) 2002-03-28 2005-02-09 Synthon Bv Besilato de venlafaxina
DE10359154A1 (de) 2003-12-16 2005-07-28 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
WO2006043577A1 (ja) * 2004-10-20 2006-04-27 Mitsubishi Pharma Corporation フェニルエタノールアミン化合物の製造方法及びその中間体
WO2007047972A2 (en) * 2005-10-19 2007-04-26 Teva Pharmaceutical Industries Ltd. Process for the preparation of highly pure 1-[2-dimethylamino-(4-methoxyphenyl) ethyl]cyclohexanol hydrochloride
WO2007049302A2 (en) * 2005-10-28 2007-05-03 Ind-Swift Laboratories Limited An improved process for the preparation of pure venlafaxine
EP2032521B1 (en) 2006-06-27 2009-10-28 Sandoz AG New method for salt preparation
AR062064A1 (es) * 2006-07-14 2008-10-15 Medichem Sa Prcesos mejorados para preparar una base de venlafaxina y sus sales
KR101640808B1 (ko) * 2010-10-01 2016-07-19 산동 루예 파마슈티칼 컴파니 리미티드 4-[2-디메틸아미노-1-(1-하이드록시사이클로헥실)에틸]페닐 4-메틸벤조에이트 하이드로클로라이드의 다형체, 이의 제조 방법 및 이의 용도
TWI665190B (zh) 2013-11-15 2019-07-11 阿克比治療有限公司 ｛［５－（３－氯苯基）－３－羥基吡啶－２－羰基］胺基｝乙酸之固體型式，其組合物及用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4611078A (en) * 1983-10-26 1986-09-09 American Home Products Corporation Substituted phenylacetonitriles
AR255595A1 (hu) 1994-07-13 2002-05-24 Gador Sa
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
CA2426393C (en) * 2000-10-31 2012-05-29 Ciba Specialty Chemicals Holding Inc. Crystalline forms of venlafaxine hydrochloride
AU2001235970A1 (en) * 2000-12-07 2002-06-18 Dr. Reddy's Research Foundation Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Also Published As

Publication number Publication date
NO20031743D0 (no) 2003-04-15
DE01988460T1 (de) 2004-04-22
SK5762003A3 (en) 2003-11-04
JP2008239629A (ja) 2008-10-09
WO2002045658A2 (en) 2002-06-13
IL196287A0 (en) 2011-08-01
AU2002241764A1 (en) 2002-06-18
HUP0303496A2 (hu) 2004-01-28
WO2002045658A3 (en) 2003-01-16
EP1334082A4 (en) 2006-02-01
MXPA03003459A (es) 2005-04-29
CZ20031298A3 (cs) 2003-10-15
HRP20030392A2 (en) 2005-04-30
US20020143211A1 (en) 2002-10-03
CN1620420A (zh) 2005-05-25
YU30203A (sh) 2006-08-17
KR20030059206A (ko) 2003-07-07
EP1334082A2 (en) 2003-08-13
IL155400A0 (en) 2003-11-23
HUP0303496A3 (en) 2005-08-29
ES2206082T1 (es) 2004-05-16
IS6789A (is) 2003-04-15
PL365895A1 (en) 2005-01-10
JP2004530638A (ja) 2004-10-07
CA2426158A1 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
NO20031743L (no) Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav
NO20042932L (no) En ny polymorf form av sertralin-hydroklorid og preparater som inneholder denne, samt nye fremgangsmater for fremstilling av polymorfe former og en amorf form av sertralinhydroklorid
NO20031694L (no) Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament
DK1373224T3 (da) Nye spirotricykliske derivater og deres anvendelse som phosphodiesterase 7 inhibitorer
IL162253A0 (en) Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
IL149222A0 (en) Stable polymorph of n-(3-ethynlamino)-6,7-bis (2-metoxyethoxy)- 4-quinaolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
NO20015113D0 (no) Nye forbindelser, deres fremstilling og anvendelse
NO20035696D0 (no) Krystallinsk anti-cholinergikum, fremgangsmåte for fremstilling derav og anvendelse derav til fremstilling av et legemiddel
IL153864A0 (en) Cyclic polyamine compounds and methods for the preparation thereof
NO20005266L (no) Nye substituerte amider, deres fremstilling og anvendelse
EE04234B1 (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
AP2004002989A0 (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
AU1234002A (en) Crystalline forms of venlafaxine hydrochloride
IS7289A (is) Kristallaður venlafaxínbasi og nýir fjölgervingarvenlafaxínhýdróklóríðs, aðferðir til að framleiðaþá
NO20015058L (no) Nye ribose-substituerte aromatiske amider, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
DK1098891T3 (da) Polycycliske thiazolidin-2-yliden-aminer, fremgangsmåde til fremstilling deraf og deres anvendelse som lægemidler
IL162255A0 (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
IL159266A (en) Crystalline forms of fexofenadine and processes for the preparation thereof
ZA200405245B (en) Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
ITMO20010077A0 (it) Mezzi di supporto per decorazioni sublimabili e metodo relativo
NO20040479L (no) Solvater av lerkanidipinhydroklorid og nye krystallinske former av lerkanidipinhydroklorid.
ITMI20001457A0 (it) Procedimento per la produzione di ammine aromatiche
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
DK1265856T3 (da) Hidtil ukendt fremgangsmåde til fremstillingen af alpha-(2,4-disulfophenyl)-N-tert-butylnitron og farmaceutisk acceptable salte deraf
NO20014077L (no) Fremgangsmåte for krystallisering av N-(4-trifluormetylfenyl)- 5-metyl-isoksazol-4-karboksamid

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application